AFJK AFJK
Company Profile ↓Company Overview
AFJK (AFJK) is a publicly traded company listed on with a market capitalization of $38.15M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Carries low leverage with a debt-to-equity ratio of 0.25.
Recent Developments
- Trailing 12 Months Year-on-year growth — earnings -58.5%.
- 5-Year Trend Long-term compounding — profit CAGR -58.5%.
Growth & Price Performance
Compounded Profit Growth
| 5 Years: | -58.48% |
| 1 Year: | -58.48% |
Stock Price Performance
| 1 Year: | +7.88% |
| 6 Months: | -77.69% |
| 3 Months: | -73.22% |
| 1 Month: | -54.85% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)24.44 · Oversold
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
No notable strengths flagged.
CONS
- Trading at a high P/E of 70.9.
- Earnings shrank at -58.5% CAGR over 5 years.
- Trading 86.4% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
- RSI at 24 suggests oversold conditions.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Jun 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | - | - | - | - | - | 413.41K | 41.60K | 130.15K | 250.59K | 61.98K |
| Operating Income | - | -153.63K | -309.11K | -200.02K | - | -413.41K | -41.60K | -130.15K | -250.59K | -61.98K |
| EBITDA | - | - | - | - | - | -413.41K | -41.60K | -130.15K | -250.59K | -61.98K |
| Interest Expense | - | - | - | - | - | - | - | - | - | - |
| Pretax Income | - | - | - | - | - | 184.66K | 424.97K | 352.02K | 98.12K | 45.44K |
| Tax Provision | - | - | - | - | - | - | - | - | - | - |
| Net Income | -3.62K | 755.50K | 609.09K | 743.51K | - | 184.66K | 424.97K | 352.02K | 98.12K | 45.44K |
| Diluted EPS | - | - | - | - | - | 0.03 | 0.07 | 0.06 | - | 0.01 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2024 | Dec 2025 |
|---|---|---|
| Revenue | 0 | 0 |
| Cost of Revenue | - | - |
| Gross Profit | - | - |
| Operating Expenses | 1.06M | 835.76K |
| Operating Income | -1.06M | -835.76K |
| EBITDA | -1.06M | -835.76K |
| Interest Expense | - | - |
| Pretax Income | 2.55M | 1.06M |
| Tax Provision | - | - |
| Net Income | 2.55M | 1.06M |
| Diluted EPS | 0.28 | 0.17 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| Total Assets | 70.47M | 73.81M | 12.10M |
| Current Assets | 580.72K | 30.38K | 2.93K |
| Cash & Equivalents | 580.72K | 28.21K | 2.93K |
| Inventory | - | - | - |
| Receivables | - | - | - |
| Total Liabilities | 714.84K | 1.51M | 4.06M |
| Current Liabilities | 24.84K | 816.99K | 3.37M |
| Long Term Debt | - | - | - |
| Total Debt | - | 227.70K | 2.02M |
| Total Equity | 69.76M | 72.31M | 8.04M |
| Shares Outstanding | 9.03M | 9.03M | 3.17M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2024 | Dec 2025 |
|---|---|---|
| Operating Cash Flow | -672.29K | -565.10K |
| Investing Cash Flow | -277.70K | 63.58M |
| Financing Cash Flow | 397.48K | -63.04M |
| Capital Expenditure | - | - |
| Free Cash Flow | -672.29K | -565.10K |
| Net Change in Cash | -552.51K | -25.28K |
Ratios (Annual)
Figures in %.
| Metric | Dec 2024 | Dec 2025 |
|---|---|---|
| Gross Margin % | - | - |
| Operating Margin % | - | - |
| Net Margin % | - | - |
| ROE % | 3.5% | 13.2% |
| ROCE % | -1.5% | -9.6% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for AFJK
W. R. Berkley (AFJK) files Schedule 13G/A showing no Aimei Health ownership - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiywFBVV95cUxQRHN6bkRFSzY2UmtNMUUzcWZxczRkU3p2b1AxZVFGNVJ5ajRFNkZJX2hod0QtVGU5YzM1WnRDSFJZVUtZcTVlV19FQXlGZU9YOUs2VUIyUnE0N21vcUEyM1JpOFNZNnl1eUtQNjhZcWdzSW5CN1dkMFo5RTRPNU1Bel9Vdmx3Nm5GWURjdk…
Aimei Health Technology (NASDAQ:AFJK) Stock Price Up 4.2% - Here's Why - MarketBeat
<a href="https://news.google.com/rss/articles/CBMitwFBVV95cUxNRTdpUnVDckljby1rWGp5SXQ5RlpMMHExQXJQa2F6aVVSR3Q5ZFcybHU5OTJuQzExRGJEQTBHdm10UlpzdGxwckRwbjA3OEZUNHVHLWM0ZVBpenVFUVlpazV5V1gtVFFmTzZ1Rl9qLUtTam13RmlCRUQ5Sjl1ZWxtVGdYUHM5S0pSWVV5Rl…
Aimei Health Technology Stock Drop Looks Sharp, But How Deep Can It Go? - Trefis
<a href="https://news.google.com/rss/articles/CBMi1wFBVV95cUxOOExyU3dpMkxHSjJsTnFuVXpwaDhpVzhFcTdEMFlCNUNyaW9QdjU2OUFSaTdRcFdiWGJuZXBrZThiRlZFWHZSdG1xZk5BUDFUa2NXNGFLMXMwOVhlRFg3bm0xb1BOWlNDdEtfWkdfelVmMFpGOEVjZ2FjWk51WldoNFE2QTdSck92U3p5V0…
AFJK Should I Buy - Intellectia AI
<a href="https://news.google.com/rss/articles/CBMiXkFVX3lxTE42RThJNVQ2XzczM3NOeGhSb3R3Rlo0MU9TbmV0NnhRVEpMMXEzRUZDbWdoV1d2MFBGcDNoSHhzbjdNbDlXY2RVZE1NLXJ2dWp5bk92LWswYTNIanZFVlE?oc=5" target="_blank">AFJK Should I Buy</a> <font c…
AFJK Q1 2026 Earnings: EPS of $0.01 Reported, Stock Moves 0.08 - Balance Sheet Strength - dars.gov.et
<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxPcm1LZE5ieXZrUGhSeFhKYktJVEhsVDJLWU9Wbi11QndDSVJlUzg5UXZpSG5mUy1FeWttaVFhLWRoWEJvVEozUFdEN2ZZY1NyOUROSHVwcG9xLTZINGEzQThaWjdrTWJBMWhzNzFpa2VnOG40VW5kQnlzQk50bzBVN2NxU2dpMTU5MjlfWV…
Crude Oil Gains 5%; Fastenal Shares Fall After Q1 Earnings - Benzinga
<a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxQZzlPYmVEQVZ0NDRDX3pkWGxGVWgzSlZ0bmxSODhlRmQ3bFhHb2h3QUpSMU1WOVU5ajEtbTFqWmkzWWxaNmVDYWhwbFZKQnBSdThXeDVFeFdLc21xUWw1VmRwOWN4VFRkUno0ZjFfUnROUWs1MnB0eTkySGdBdDBqQmRiRmVUTlk0ZlBPRE…
AFJK — Frequently Asked Questions
What is the current share price of AFJK?
As of 2026-08-05 17:25 PDT, AFJK trades at $12.05 on NASDAQ/NYSE. Its 52-week range is $8.00 to $88.50.
What is the market capitalisation of AFJK?
AFJK has a market capitalisation of $38.15M on NASDAQ/NYSE.
What is the P/E ratio of AFJK?
AFJK trades at a trailing price-to-earnings (P/E) ratio of 70.88. Its price-to-book (P/B) ratio is 4.74.
What is the return on equity (ROE) of AFJK?
AFJK has a return on equity (ROE) of 13.18%. Its return on capital employed (ROCE) is -9.57%.
Is AFJK a good stock to buy?
This page provides a data-driven analysis of AFJK, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.